4Naziwek-Siewniak B, Moczulsik D, Grzeszczak W. Risk of macrovascular and microvascular complications in type 2 diabetes : results of longitudinal study design[J]. J Diabetes Complic,2002,16(7) :271-276.
5Romano Nosadini. Blood glucose in relation to blood pressure control as risk factors in the progression of renal damage in type 2 diabetes[J].Int Congr Series, 2000, 1253:295-299.
6Adler AI, Stevens R J, Manley SE, et al. Development and progression of nephropathy in type 2 diabetes:the united Kingdom prospective diabetes study (UKP DS 64) [J]. Kidney Int, 2003,63 : 225-232.
7Naziwek-Siewniak B,Moczulsik D,Grzeszczak W.Risk of macrovascular and microvascular complications in type 2 diabetes:results of longitudinal study design[J].J Diabetes Complic,2002,16(7):271.
8Krolewski AS.Genetics of diabetic nephrollhy:evidence for major and mininor gene effccts.Kidney,l999,55(4):1582-1596.
9Rogus JJ,Krolewski AS.Using g discordant sib-pairs to map loci for qualitative traits with high sibling recurrence risk.Am J Hum Genet,1996,59(6):1376-1381.
10Faronato PP,Maioli M,Tonolo G,et al.Clustering ofalbumin excretion rate abnormalities in Caucasian patients with NIDDMM:the Italy NID-DM nephropathy study group.Diabetologia,1997,40(7):816-823.
